Erasmus syndrome presented as CREST syndrome with Scl-70 positivity: a case report
Article Sidebar
Main Article Content
Abstract
Erasmus syndrome is a rare pathology defined as a systemic sclerosis secondary to contact with silica, associated or not with silicosis. More recent studies have related silica as an environmental factor stimulating different immune responses of the body. This report was made with the objective of presenting a rare case of systemic sclerosis, in a localized cutaneous form, also called CREST syndrome. A patient with a 20-year history of mining developed silicosis, cutaneous calcinosis, Raynauld's phenomenon, esophagopathy, sclerodactyly, telangiectasias and high positivity for the antitopoisomerase I antibody, the most common antibody in the systemic form.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Erasmus LD. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. South Afr J Lab Clin Med Suid-Afr Tydskr Vir Lab- En Kliniekw. setembro de 1957;3(3):209–31.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. fevereiro de 1988;15(2):202–5.
Bramwell B. Diffuse scleroderma: Its frequency; its occurrence in stonemasons. Edinburgh Med J 1914;12:387-401.
Aryal BK, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med. 29 de agosto de 2001;40(3):271–4.
Zimmermann AF, Pizzichini MMM. Atualização na etiopatogênese da esclerose sistêmica. Rev Bras Reumatol. novembro de 2013;53(6):516–24.
de Miranda AAM, Nascimento AC, Peixoto IL, Scrignoli JA, Lucena Cardoso M do S de, Euzébio Ribeiro SL. Síndrome de Erasmus – silicose e esclerose sistêmica. Rev Bras Reumatol. maio de 2013;53(3):310–3.
Denton CP, Khanna D. Systemic sclerosis. The Lancet. outubro de 2017;390(10103):1685–99.
Rocha LF, Luppino Assad AP, Marangoni RG, Del Rio APT, Marques-Neto JF, Sampaio-Barros PD. Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort. Rheumatol Int. maio de 2016;36(5)
Velayos EE. The “CREST” syndrome. Comparison with systemic sclerosis (scleroderma). Arch Intern Med. 1o de novembro de 1979;139(11):1240–4.
Skare TL, Fonseca AE, Luciano AC, Azevedo PM. Autoanticorpos em esclerodermia e sua associação ao perfil clínico da doença: estudo em 66 pacientes do sul do Brasil. An Bras Dermatol. dezembro de 2011;86(6):1075–81.
Yáñez Diaz S, Morán M, Unamuno P, Armijo M. Silica and Trichloroethylene-Induced Progressive Systemic Sclerosis. Dermatology. 1992;184(2):98–102.